the Dalmatian, Leonberger, Pyrenean Mountain Dog, Greyhound, Alaskan Malamute, Boxer, Black Russian Terrier, and Rottweiler, with variable ages of onset, clinical signs, and prognosis. [2] [3] [4] [5] [6] [7] [8] [9] [10] So far, such a disease has not been described in American Staffordshire Terriers (ASTs).
Inherited PNs can either be syndromic, as part of a degenerative process involving the central and peripheral nervous system, or nonsyndromic, with clinical signs only related to PN. 1 In the Black Russian
Terrier, Rottweiler, and Boxer, the disease is syndromic with vacuolation in the neuronal cell bodies, axons and adrenal cells, and ocular abnormalities, similar to Warburg syndrome in humans. 8, 9, 11 A causative mutation in the RAB3GAP1 gene has been identified in the Black Russian Terrier and Rottweiler. 9, 11 In the other breeds, nonsyndromic forms lead to a disease similar to Charcot-Marie-Tooth (CMT) disease in humans, with axonal degeneration being a dominant finding. [2] [3] [4] [5] [6] [7] 12, 13 Mutations have been found for the Alaskan Malamute and Greyhound (NDRG1 gene), and for the Leonberger (ARHGEF10 and GJA9 genes), which allows for genetic screening. 5, 14, 15 In most breeds, disease prognosis is reported to be poor, with death or euthanasia occurring shortly after diagnosis. 1,2,4,5,7 Some
Alaskan Malamutes and Leonbergers have been reported to have progressive disease with survival ranging from several months to several years. 7, 12 To date, the only inherited degenerative disorder described in the AST is ceroid lipofuscinosis. In this breed, an arylsulfatase G (ARSG) mutation leads to a sulfatase deficiency and therefore to neuronal ceroid lipofuscinosis, eventually resulting in neuronal apoptosis and adult-onset cerebellar ataxia. 16, 17 We have observed a progressive neurological disorder with juvenile-onset locomotor and respiratory signs and neurological examination findings consistent with PN in the AST. The aims of our study were to establish the phenotype of this newly described disorder, to determine its prognosis and to investigate the possibility of a genetic origin.
| MATERIALS AND METHODS

| Case selection
Fourteen ASTs that showed clinical signs consistent with a PN with or without respiratory signs including inspiratory stridor and dyspnea, consistent with LP, of juvenile onset were presented between May 2005 and July 2017, and retrospectively included in the study. All dogs were confirmed to have degenerative PN after histological evaluation of peripheral nerve biopsy samples.
| Clinical and pathological evaluation
Clinical records were analyzed and results of clinical and neurological evaluations were reviewed. Results of additional diagnostic evaluation, such as hematology, serum biochemistry profile, assessment of thyroid function, cerebrospinal fluid analysis, infectious disease testing and results of diagnostic imaging, including thoracic radiographs, magnetic resonance imaging (MRI) and laryngoscopy were reviewed when available, as well as information regarding outcome after several months to years. Nerve biopsy samples were taken from all dogs. Peroneal nerve biopsies were available for all dogs. Further biopsy sites were the recurrent laryngeal nerve (dog 9) and the ulnar nerve (dogs 9 and 14).
| Electrodiagnostic testing
All nerve biopsy samples, except those from dog 2, were routinely fixed in 2.5% glutaraldehyde and contrasted with osmium tetroxide.
One sample was embedded in epoxy resin whereas another underwent nerve fiber teasing, for longitudinal analysis. 19 The embedded tissues were sectioned at 0.5 μm, stained with azure II methylene blue-safranin O and examined microscopically according to standard algorithms. 19 For dog 2, the nerve was routinely stained with H&E.
Based on the extent of nerve fiber lesions (including fiber loss, demyelinative changes, node-paranode disruption and axonal degeneration) and regenerative changes (including remyelination, axonal sprouts, and regenerative clusters), the overall severity of nerve lesions was graded semiquantitatively as mild (+), moderate (++), or marked (+++).
One dog (dog 9) was euthanized because of respiratory distress, and the entire nervous system was obtained and analyzed post mortem.
| Pedigree analysis
All available pedigrees were compiled and the familial relationships among the dogs were investigated. Information about the disease status of the parents and littermates was reviewed when available. 
| Clinicopathological findings
Results of routine biochemical analyses and CBC, available for 10 and 6 dogs, respectively, were within reference ranges, as was the albumin to globulin ratio. Creatine kinase activities were mildly but increased analysis was within reference ranges. Serological tests were performed in 2 dogs for neosporosis and 3 dogs for toxoplasmosis, and results were negative.
| Imaging
Magnetic resonance imaging of the brain and cervical spinal cord was performed in 2 dogs and results were normal in 1 dog. In the other dog, MRI disclosed a decreased cerebellar size associated with increased size of the cerebellar sulci. Thoracic radiographs, performed in 3 dogs, were normal in 2 dogs and showed megaesophagus in 1 dog (dog 9) with regurgitation. Laryngoscopy was performed in 7 dogs with respiratory signs and was consistent with bilateral LP. Endoscopy of the esophagus was performed in dog 9 and was consistent with megaesophagus, with decreased esophageal motility reported.
| Electrodiagnostic testing
Electrodiagnostic tests were performed in 13 dogs and results were consistent with generalized, predominantly axonal and demyelinating, Table 1 and compared with published data.
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A summary of the data for individual dogs is available in Supporting Information Table S2 . 
| Histopathology
The results of histopathological analysis of the muscle and nerve biopsy samples are presented in Table 2 . 
| Follow-up
Three dogs were lost to follow-up. Follow-up (up to 6 years after diagnosis) was available for 11 dogs. Three dogs were euthanized shortly 
| Pedigree analysis
The 14 dogs came from 11 different litters and 3 dogs were siblings.
Six pedigrees (for 8 dogs) were reviewed and a 5-generation pedigree analysis was performed. The family pedigree of the dogs is shown in Figure 5 . Genetic analysis determined that 6 dogs had a common ancestor. The other 2 dogs were not related to this family. Many inbreeding loops were identified and 1 dog was a backcross. Both males and females were affected, and none of the parents was reported to have had clinical signs. Data concerning disease status could not be obtained for all the littermates. Nevertheless, the prevalence of the disease in 2 litters of the family pedigree with littermates was at least 25%.
| DISCUSSION
We describe a novel motor and sensory, distal and mainly axonal, degenerative nonsyndromic PN of juvenile onset in AST with fair prognosis in comparison with data reported for other breeds.
The disease is very likely to be nonsyndromic in AST, whereas in the Rottweiler, Black Russian Terrier, and Boxer, PN with LP is a syndromic disease. In these breeds, affected dogs also exhibit ophthalmologic abnormalities such as microphthalmia, cataracts, miotic pupils, and persistent pupillary membranes. [8] [9] [10] [11] 20 None of the dogs included in our study exhibited microphthalmia, miotic pupils, or persistant pupillary membranes although full ophthalmological examination was available only for 3 dogs. Retinal dysplasia was identified in 1 dog.
This finding has not been reported in PN with ocular abnormalities and neuronal vacuolation and is in itself thought to be an inherited ocular disorder in ASTs. 21 Brain MRI examinations are not reported in syndromic polyneuropathy of Rottweiler, Black Russian Terrier, and Boxer, except for 1 case, a Rottweiler, in which brain MRI was normal. 22 This examination, available for 3 dogs from our cohort, disclosed central nervous system involvement in only 1 case. In this dog, slight cerebellar atrophy was observed without clinical signs of cerebellar dysfunction. This anomaly is probably not associated with AST PN and could represent an incidental finding. This cerebellar atrophy remains of unknown origin because neither genetic testing for the canine arylsulfatase G mutation nor histopathology of the cerebellum was performed. The parents of this dog were not tested either.
Regarding the age of the dog, it is unlikely the result of ceroid lipofuscinosis, and congenital anomaly should be considered. Another argument against syndromic PN is that complete histology of the entire nervous system in 1 affected dog failed to identify any lesions in 1 affected dog. ASTs. However, in a study that investigated esophageal function in dogs with idiopathic LP, the authors found that most of the dogs (25/32) had abnormal esophageal motility, but less than one-third of these dogs had clinical signs of dysphagia. 29 For these reasons, On the contrary, the combination of myelin sheath changes in older dogs might be seen in metabolic disorders such as Cushing's disease and insulinoma. Moreover, an association with risk of immunemediated neuropathy requires consideration.
In the other breeds, PN and LP have been reported to be associated with poor prognosis resulting in death or euthanasia a few months after diagnosis, often as a consequence of aspiration pneumonia, despite palliative treatment. 2, 4, 5, 7 Nine of the 11 Alaskan Malamutes included in a previous study were euthanized soon after diagnosis, because of their poor condition, but 2 dogs were still alive 36 and 42 months, respectively, after diagnosis, and thus the disease may be slowly progressive. 7 In the Leonberger, prognosis is reported to be fair, with gradual clinical worsening within months to a few years. In another study, 9 of the 21 dogs received surgical correction for LP, resulting in clinical improvement. 12 In 2 dogs, locomotor weakness progressed to quadriplegia. At the end of the study, 8 dogs were alive and still ambulatory, and the other dogs were euthanized, died of aspiration pneumonia or were lost to follow-up. Duration of follow-up was not specified. The prognosis was reported to be worse for dogs in which the onset of clinical signs occurred earlier and the course of the disease was more severe and progressed more rapidly. 12 The disease prognosis in AST seems to be fair in comparison to other breeds, and many dogs survive for a longer time that has been reported in other breeds. The severity of the clinical signs in our dogs was variable. Two dogs with both locomotor and respiratory signs were euthanized soon after diagnosis because of their poor medical condition. One of these dogs had megaesphagus and regurgitation. In the dogs with respiratory and locomotor signs, for which follow-up was available, LP was responsible for acute worsening of clinical signs, but both dogs improved after surgery. Regarding those dogs with locomotor signs only, 1 was euthanized at the owner's request but was still ambulatory before euthanasia, and 3 dogs were still alive, with a slowly progressive disorder, 6 months to 2 years after diagnosis. For dogs presented with locomotor signs only, the prognosis seems to be good and it seems to be fair for dogs presented with LP, once surgery has been performed. The rare occurrence of clinical megaesophagus, associated with a higher risk for secondary aspiration pneumonia, might explain the better prognosis in comparison to the Dalmatian and Pyrenean
Mountain Dog.
To some extent, the progression of PNLP in AST seems comparable to the progression of CMT disease in humans, which typically occurs during the first or second decade of life and is slowly progressive with no alteration of life expectancy in most cases. 33, 34 The natural history of axonal degenerative PNs, or type 2 CMT, was studied prospectively over 5 years. 3 Very few patients were nonambulatory at the beginning of the study. The disease typically was slowly progressive, but none of the initially ambulatory patients lost their ability to walk during the follow-up period. 35 Some patients with severe disease are unable to ambulate in infancy or early childhood. 34 Vocal cord dysfunction caused by vagus and laryngeal neuropathies has been reported in association with several CMT types, and this dysfunction is not related to the severity of neuromuscular weakness. 34 Both laryngeal and pharyngeal dysfunction can occur in hereditary and acquired neuropathy with axonal involvement, and also in acquired, immune-mediated nodal-paranodal neuropathy. 19 The juvenile onset of clinical signs in our dogs is consistent with an inherited disorder. Both males and females were affected, and none of the parents was reported to have clinical signs. Some pedigrees are missing and data concerning disease status could not be obtained for all of the littermates. Nevertheless, the prevalence of the disease in the aforementioned litters was at least 25%. For all these reasons, an AR mode of inheritance can be suspected. Additional data are needed to confirm that the disease is inherited and to identify its mode of inheritance.
To our knowledge, ours is the first description of juvenile PNLP in
ASTs. The disease results from degenerative neuropathy and very likely is inherited. When surgery for LP is performed, the majority of
